about
Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS AutoimmunityLong-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies.Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML.Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy.Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy.Clinical use of lentiviral vectors.Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway.
P2860
Q37256159-CDAB0F12-8A23-459A-B6B0-057ED0EDB3DCQ37410746-75022D19-9301-4843-A37B-2299F748546AQ38731982-5075631D-D2EE-4437-BCE8-E4ABF4DC22F2Q38756454-AA7FDE7E-A11E-4499-A1AF-59901691FBCEQ41909592-BF3C7DBA-E7D7-4A85-9B3B-84297F40D9F0Q47216941-F957F7D0-0912-42E7-ABB4-39162EF07313Q52431278-50F26379-F961-4007-A58B-55C8C68BBE74Q52589095-B9D66650-CCC4-4DA8-803C-9967AED5D59BQ52718423-51C32E2B-7BC1-4AFE-BDB5-91319BE54496
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lentiviral vectors in cancer immunotherapy.
@en
type
label
Lentiviral vectors in cancer immunotherapy.
@en
prefLabel
Lentiviral vectors in cancer immunotherapy.
@en
P2093
P2860
P356
P1433
P1476
Lentiviral vectors in cancer immunotherapy.
@en
P2093
Elliot M Berinstein
Jeffrey A Medin
Robyn Aa Oldham
P2860
P304
P356
10.2217/IMT.14.108
P577
2015-01-01T00:00:00Z